Zila, Inc. has announced that its new oral screening technology ViziLite Plus, will be exclusively distributed by DentalMed Russian Alliance in Russia and Belarus. The Russian company will also be distributing TBlue(TM), the oral cancer screening product owned by Zila. DentalMed has begun the registration for the product and will start training its sales representatives and preparing the market for the product launch. ViziLite Plus utilizes a chemiluminescent light source and a patented vital tissue dye (TBlue). It will help dentists to identify and evaluate abnormalities in the mouth that have the potential to harbor pathological changes. The ViziLite Plus is a non-invasive exam It does  not cause much discomfort and is over in just a few minutes.